Advisory Board Member - Help Change What an Alzheimer's Diagnosis Means

ABOUT ALZHEIMER'S TREATMENT CENTERS OF AMERICA

Alzheimer's Treatment Centers of America (ATCA) is redefining the future of Alzheimer's and cognitive decline care through a precision medicine approach that goes beyond symptom management. By integrating advanced diagnostics, biomarker testing, artificial intelligence, genetics, and personalized treatment strategies, ATCA is building a scalable clinical platform designed to improve outcomes while transforming how cognitive care is delivered.

As the organization expands nationally, ATCA is assembling an accomplished Strategic Advisory Board to help guide growth, strengthen industry partnerships, and accelerate commercialization.

ABOUT THE ROLE

Strategic Advisor – AI-Powered Alzheimer's Care is a high-impact advisory role for accomplished healthcare executives, physicians, entrepreneurs, investors, operators, and innovation leaders who are passionate about leveraging artificial intelligence and precision medicine to transform Alzheimer's care.

Advisory Board Members provide strategic insight as ATCA expands its AI-enabled clinical platform, develops national partnerships, and scales innovative approaches to cognitive healthcare. Members collaborate with nationally recognized physicians, healthcare innovators, and executive leaders working to build the future of personalized brain health.

This advisory position requires approximately 1–2 hours per month.

KEY RESPONSIBILITIES

• Advise leadership on AI strategy, commercialization, healthcare innovation, and organizational growth.

• Provide strategic guidance on reimbursement, operations, partnerships, and national expansion.

• Introduce strategic relationships across healthcare systems, life sciences, digital health, technology companies, employer health, and investment communities.

• Participate in periodic virtual Advisory Board meetings and provide ongoing strategic insight.

• Help shape the future of AI-driven precision medicine for Alzheimer's disease and cognitive decline.

PREFERRED QUALIFICATIONS

We welcome applications from accomplished leaders with experience in one or more of the following:

• Healthcare executive leadership

• Physicians with leadership, innovation, or practice-building experience

• Artificial intelligence, machine learning, or healthcare technology

• Digital health or software-enabled healthcare

• Biotechnology, diagnostics, pharmaceutical, or medical device industries

• Healthcare entrepreneurship or company scaling

• Corporate strategy, business development, or innovation

• Private equity, venture capital, family office, or healthcare investing

• Health systems, payer organizations, or value-based care

• Board, advisory board, or governance experience

Ideal candidates include physicians, healthcare executives, founders, operators, entrepreneurs, investors, and technology leaders with a demonstrated history of building organizations, leading innovation, scaling businesses, or influencing strategic healthcare initiatives.

COMPENSATION & BENEFITS

• Opportunity to receive sweat equity

• Participation in carried interest programs, where applicable

• Collaborate with nationally recognized healthcare leaders

• Flexible commitment of approximately 1–2 hours per month

• Help shape the future of AI-powered precision brain health

• Qualified Advisory Board Members may have the opportunity to participate in future angel investment opportunities with the Company.

WHY JOIN ATCA

Artificial intelligence is rapidly transforming healthcare, and Alzheimer's disease remains one of medicine's greatest unmet challenges. This is an opportunity to help guide a company combining AI, precision medicine, and personalized care to redefine how cognitive decline is diagnosed, treated, and managed while creating meaningful long-term enterprise value.

EQUAL OPPORTUNITY

Alzheimer's Treatment Centers of America is committed to building a diverse Advisory Board and welcomes qualified applicants from all backgrounds and experiences.